Status message

Not the entire site translated, but only to "Journal"

Catatonia: patophysiology, diagnosis and contemporary treatment approaches

A.E.Konoreva, E.E.Tsukarzi, S.N.Mosolov
Federal State Budgetary Institution “Federal Medical Research Centre for Psyciatry and Narcology” of the Ministry of Health of the Russian Federation, Moscow, Russia
Summary: This article presents a review of evidence-based studies on the problem of diagnosis, pathophysiology and treatment of catatonia. Catatonic syndrome (CS) is represented by a wide range of motor, speech and behavioral disorders and is currently regarded as a polietiologic condition, which is based on both psychiatric and non-psychiatric reasons. According to recent data bipolar disorder is the most common psychiatric cause of catatonia, while the occurrence of catatonia in schizophrenia occurs less frequently. The article also considers various therapeutic approaches to CS, among which benzodiazepines and electroconvulsive therapy play a primary role.

Contact: profmosolov@mail.ru

References: 

1. Abrams R., Taylor M.A. Catatonia: a prospective clinical study // Arch Gen Psychiatry. – 1976. – Vol. 33. – P. 579–581.
2. Fink M.T., Taylor M.A. Catatonia A clinician’s guide to diagnosis and treatment. – Cambridge, UK: Cambridge University Press, 2003. –256 p.
3. Francis A., Fink M., Appiani F. Catatonia in diagnostic and statistical manual of mental disorders, fifth edition// J ECT. – 2010. – Vol. 26. – P. 246–247.
4. Kleist K., Driest W. Catatonia revealed by follow-up studies: Part I, degeneration psychosis which were mistaken for catatonias // Z Ges Neurol Psychiat. – 1937. –Vol. 157. –P. 479–487.
5. Fornaro M. Catatonia: A Narrative Review // Central Nervous System Agents in Medicinal Chemistry. – 2011. – Vol. 11, No. 1. – P. 73–79.
6. Rosebush P.I., Hildebrand A.M., Furlong B.G., Mazurek M.F. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam // J Clin Psychiatry. – 1990. – Vol. 51 (9). – P. 357–362.
7. Taylor M.A.. Fink M. Catatonia in psychiatric classification: A home of its own // Am J Psychiatr. – 2003, Jul. – Vol. 160 (7). – P. 1233–1241.
8. Fein S., McGrath M. Problems in diagnosing bipolar disorder in catatonic patients // J Clin Psychiatry. – 1990. – Vol. 51. – P. 203–205.
9. Francis A. Catatonia: diagnosis, classification, and treatment // Curr Psychiatry Rep. – 2010. –Vol. 12. – P. 180–185.
10. Medda P., Toni C., Luchini F., Giorgi Mariani M., Mauri M., Perugi G. Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy // Bipolar Disord. – 2015. – Vol. 17 (8). – P. 892–901.
11. Smith J.H., Smith V.D., Philbrick K.L. et al. Catatonic disorder due to a general medical or psychiatric condition // J Neuropsychiatry Clin Neurosci. – 2012. – Vol. 24. – P. 198–207.
12. Kahlbaum K.L. Catatonia. Translated by Levi Y., Pridon T. – Chichester: John Wiley, for The Johns Hopkins University Press, 1973. – P. xviii + 96.
13. Kirby G. Catatonic syndrome and its relations to manic-depressive illness // J Nerv Ment Dis. – 1913. –Vol. 40. – P. 694–704.
14. Abrams R., Taylor M. Catatonia. A prospective clinical study // Arch Gen Psychiatry. – 1976, May. – Vol. 33 (5). – P. 579–581.
15. Mosolov S.N., Tsukarzi E.E., Malin D.I. Neotlozhnye sostoyaniya v psikhiatrii // Ratsional'naya farmakoterapiya neotlozhnykh sostoyanii / pod red. B.S. Briskina, A.L. Vertkina. – M.: Litera, 2007. – S. 422–461.
16. Bush G., Fink M., Petrides G. Catatonia. I. Rating scale and standardized examination // Acta Psychiatr. Scand. – 1996. – Vol. 93 (2). – P. 129–136.
17. Sienaert P, Rooseleer J, De Fruyt J. Measuring catatonia: a systematic review of rating scales // J Affect Disord 2011;135:1–9.
18. Northoff G. Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology // Psychiatry Res Neuroimaging. – 2002. – Vol. 109 (12). – P. 1453–1367.
19. Northoff G., Waters H., Bogerts B. Cortical sulcal enlargement in catatonic schizophrenia: a planimetric CT study // Psychiatry Res Neuroimaging. – 1999. – Vol. 91. –P. 45–54.
20. Northoff G., Steinke R., Czcervenka C. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding // J Neurol Neurosurg Psychiatry. – 1999. – Vol. 67. – P. 445–451.
21. Richter A., Gessner M., Bogerts B., Heinze H.J., Northoff G. Abnormal gaba-ergic modulation of orbitofrontal activation during emotional stimulation in catatonia: an fMRI with lorazepam (submitted) // Front Psychiatry. – 2015. Vol. 6. – P. 182.
22. Tsukarzi E.E. Sovremennye metody stimulyatsii mozga: dostizheniya i perspektivy primeneniya // Sots. i klin. psikhiatriya. – 2013. – T. 23, № 1. – S. 93–99.
23. Hatta K., Miyakawa K., Ota T. Maximal response to electroconvulsive therapy for the treatment of catatonic symptoms // J ECT. –2007. – Vol. 23 (4). – P. 233–235.
24. Jaimes-Albornoz W., Serra-Mestres J. Catatonia in the emergency department // Emerg Med J. – 2012. – Vol. 29. – P. 863–867.
25. Carroll B. Goforth H. Review of Adjunctive Glutamate Antagonist Therapy in the Treatment of Catatonic Syndromes // J Neuropsychiatry Clin Neurosci. – 2007, Fall. – Vol. 19 (4). – P. 406–412.
26. Gjessing L. Hypothalamic dysfunction in periodic catatonia // J Oslo City Hosp. – 1986. –Vol. 36. – P. 105–116.
27. Cooper S.J., Scott A.I., Whalley L.J. A neuroendocrine view of ECT // Br J Psychiatry. – 1990. – Vol. 157. – P. 740–743.
28. Carroll B., Goforth H. Medical catatonia // Caroff S., Mann S., Francis A. et al., eds. Catatonia. From Psychopathology to Neurobiology. – Washington, DC: American Psychiatric Publishing, Inc., 2004. – P. 123–125.
29. McDaniel W., Spiegel D. Hyponatremia and abnormal ingestion of water in catatonia // Prim Psychiatry. – 2010. – Vol. 17. – P. 29Y33.
30. Lucignani G., Panzacchi A., Bosio L. et al. GABA-A receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11-C]flumazenil // Neuroimage. – 2004. – Vol. 22. – P. 22–28.
31. Swaab D., Purba J., Hofman M. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases // J Clin Endocrinol Metab. – 1995. – Vol. 80. – P. 573–579.
32. Dhossche D., Wachtel L. Catatonia is hidden in plain sight among different pediatric disorders: a review article // Ped Neurol. – 2010. – Vol. 43. – P. 307–315.
33. Dalmau J., Tüzün E., Wu H. Paraneoplastic anti- N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma // Annals of Neurology. – 2007. – Vol. 61 (1). – P. 25–36.
34. Gable M.S., Sheriff H., Dalmau J. The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project // Clin Infect Dis. – 2012, Apr. – Vol. 54 (7). – P. 899–904.
35. Titulaer M.J., McCracken L., Gabilondo I. et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study // Lancet Neurology. – 2013. – Vol. 12 (2). – P. 157–165.
36. Levin O.A. Gan'kina A.Sh., Chimagomedova A.Sh. Autoimmunnyi entsefalit s antitelami k NMDA-retseptoram // Zhurnal nevrologii i psikhiatrii. – 2017. – Vol. 117 (2). – P. 110–116.
37. Malin D.I., Gladyshev V.N. Zlokachestvennyi neirolepticheskii sindrom ili autoimunnyi anti-NMDA retseptornyi entsefalit? Razbor klinicheskogo sluchaya s letal'nym iskhodom // Sotsial'naya i klinicheskaya psikhiatriya. – 2017. – T. 27, № 1. – S. 62–67.
38. Malin D.I., Ravilov R.S. Rasprostranennost', klinika, diagnostika i terapiya tyazhelykh oslozhnenii neirolepticheskoi terapii // Rossiiskii psikhiatricheskii zhurnal. – 2014. – T. 24, № 4. – S. 90–96.
39. Avrutskii G.Ya. Raiskii V.A. Tsygankov B.D. Klinika i techenie zlokachestvennogo neirolepticheskogo sindroma (ostroi febril'noi neirolepticheskoi entsefalopatii) // Zhurn. nevropatol. i psikhiatr. –1987. – Vyp. 9. – S. 1391–1396.
40. Moscovich M., Novak F., Fernandes A. et al. Neuroleptic malignant syndrome // Arq Neuropsiquiatr. –2011. – No 5. – P. 751–755.
41. Strawn J., Keck P., Jr. Caroff S. Neuroleptic malignant syndrome // Am J Psychiatr. – 2007. – Vol. 164. – P. 870–876.
42. Malin D.I., Ravilov R.S., Kozyrev V.N. Effektivnost' bromokriptina i dantrolena v kompleksnoi terapii zlokachestvennogo neirolepticheskogo sindroma // Rossiiskii psikhiatricheskii zhurnal. – 2008. – № 5. – S. 75–81.
43. Tsygankov B.D. Kliniko-patogeneticheskie zakonomernosti razvitiya febril'nykh pristupov shizofrenii i sistema ikh terapii. – M.: Norma, 1997. – 232 c.
44. Lang F.U., Lang S., Becker T., Jager M. Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma // Psychopharmacology. – 2015. – Vol. 232. – P. 1–5.
45. Saddawi-Konefka D., Berg S.M., Nejad S.H. et al. Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. A case series and review of the literature // Crit Care Med. – 2014. – Vol. 42. – P. e234–41.

46. Carroll B., Goforth H. Review of Adjunctive Glutamate Antagonist Therapy in the Treatment of Catatonic Syndromes // J Neuropsychiatry Clin Neurosci. – 2007, Fall. – Vol. 19 (4). – P. 406–412.
47. Fornaro M Catatonia: A Narrative Review // Central Nervous System Agents in Medicinal Chemistry – 2011- Vol. 11, No. 1
48. Francis A. Catatonia: diagnosis, classification, and treatment // Curr Psychiatry Rep. – 2010. – Vol. 12. – P. 180–185.
49. Volkov V.P. K voprosu o febril'noi katatonii // Sotsial'naya i klinicheskaya psikhiatriya. – 2012. – T. 22, № 2. – C. 16–20.
50. Pelzer A. Systematic review of catatonia treatment // Neuropsychiatric Disease and Treatment. – 2018. – Vol. 14. – P. 317–326.
51. Huang Y.C., Lin C.C., Hung Y.Y. Rapid relief of catatonia in mood disorder by lorazepam and diazepam // Biomed J. – 2013. – Vol. 36 (1). – P. 35–39.
52. Lin C.C., Huang T.L. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis // Compr Psychiatry. – 2013. –Vol. 54 (8). – P. 1210–1214.
53. Bahadir D. The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia: Treatment Characteristics and Outcomes in 60 Patients // The journal of ECT. – 2017. – Vol. 33 (4). – P. 290–293.
54. Tibrewal P., Narayanaswamy J., Zutshi A. et al. Response rate of lorazepam in catatonia: a developing country’s perspective // Prog Neuropsychopharmacol Biol Psychiatry. – 2010. – Vol. 34. – P. 1520–1522.
55. Dedkova A.E. Opyt effektivnogo primeneniya benzodiazepinov pri katatonii, oslozhnennoi zlokachestvennym neirolepticheskim sindromom (klinicheskoe nablyudenie) // Sovremennaya terapiya psikhicheskikh rasstroistv. – 2016. – № 2. – C. 22–26.
56. Rosebush P.I., Hildebrand A.M., Furlong B.G., Mazurek M.F. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam // J Clin Psychiatry. –1990. – Vol. 51 (9). – P. 357–362.
57. Bush G, Fink M, Petrides G Catatonia. II. Treatment with lorazepam and electroconvulsive therapy // Acta Psychiatr Scand -1996- 93:137–43.
58. Cristancho P., Jewkes D., Mon T., Conway C. Successful use of right unilateral ECT for catatonia: a case series // J ECT. – 2014. – Vol. 30 (1). – P. 69–72.
59. Dessens F.M., van Paassen J., van Westerloo D. Electroconvulsive therapy in the intensive care unit for the treatment of catatonia: a case series and review of the literature // Gen Hosp Psychiatry. – 2016. – Vol. 38. – P. 37–41.
60. Kugler J., Hauptman A., Collier S. et al. Treatment of catatonia with ultrabrief right unilateral electroconvulsive therapy: a case series // J ECT. – 2015. – Vol. 31 (3). – P. 192–196.
61. Medda P., Toni C., Luchini F., Giorgi Mariani M., Mauri M., Perugi G. Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy // Bipolar Disord. –2015. – Vol. 17 (8). – P. 892–901.
62. Raveendranathan D., Narayanaswamy J.C., Reddi S.V. Response rate of catatonia to electroconvulsive therapy and its clinical correlates // Eur Arch Psychiatry Clin Neuroscience. – 2012, Aug. – Vol. 262 (5). – P. 425–430.
63. Rohland B.M., Carroll B.T., Jacoby R.G. ECT in the treatment of the catatonic syndrome // J Affect Disord. – 1993. – Vol. 29 (4). – P. 255–261.
64. Kekelidze Z.I., Mosolov S.N., Tsukarzi E.E., Oleneva E.V. Primenenie elektrosudorozhnoi terapii v psikhiatricheskoi praktike: ucheb.-metod. posobie dlya vrachei FGBU «Natsional'nyi meditsinskii issledovatel'skii tsentr psikhiatrii i narkologii im. V.P. Serbskogo» Minzdrava RF, 2019.
65. Fink M. Electroconvulsive therapy. – New York: Oxford University Press, 2009. – 400 p.
66. Weiner R.D., Reti I.M. Key updates in the clinical application of electroconvulsive therapy // International Review of Psychiatry. – 2017. Vol. 29 (2). – P. 54–62.
67. England M.L., Ongü D., Konopaske G. Catatonia in psychotic patients: clinical features and treatment responses // J Neuropsychiatry Clin Neurosci. – 2011. – Vol. 23 (2). – P. 223–226.
68. Yoshimura B., Hirota T., Takaki M., Kishi Y. Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients // Neuropsychiatr Dis Treat. – 2013. – Vol. 9. – P. 1565–1571.
69. Alekseeva A.G., Baranov P.A., Platonova T.P., Andrienko E.V. Voprosy terapii oneiroidno-katatonicheskikh sostoyanii pri endogennykh zabolevaniyakh // Sovremennaya terapiya v psikhiatrii i nevrologii. – 2018. – №.2. – P. 38–44.
70. Martenyi F., Metcalfe S., Schausberger B., Dossenbach M.R.K. An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms // J Clin Psychiatry. – 2001. – Vol. 62, Suppl. 2. – P. 25–27.
71. Kozyrev V.N., Zelenina E.V. Opyt primeneniya olanzapina dlya parenteral'nogo vvedeniya v lechenii bol'nykh shizofreniei // Sotsial'naya i klinicheskaya psikhiatriya. 2005. – T. 15, vyp. 2. – S. 49–51.
72. Kritzinger P.R., Jordaan G.P. Catatonia: an open prospective series with carbamazepine // Int J Neuropsychopharmacol. – 2001. – Vol. 4 (3). – P. 251–257.
73. McDaniel W.W., Spiegel D.R., Sahota A.K. Topiramate effect in catatonia: a case series // J Neuropsychiatry Clin Neurosci. – 2006. – Vol. 18 (2). – P. 234–238.
74. de Lucena D.F., Pinto J.P., Hallak J.E. Short-term treatment of catatonia with amantadine in schizophrenia and schizoaffective disorder // J Clin Psychopharmacol. – 2012. – Vol. 32 (4). – P. 569–572.
75. Obregon D.F., Velasco R.M. Memantine and catatonia: a case report and literature review // J Psychiatr Pract. – 2011. – Vol. 17 (4). – P. 292–299.
76. Christopher J. Thomas Memantine in catatonic schizophrenia // American Journal of Psychiatry. – 2005. – Vol. 162 (2). – P. 626.